MedTrace Logo

Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

NCT02411461 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2019-11-13

Study results available
· View outcomes & findings →

Summary

Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other obese children.

Conditions

  • Pseudohypoparathyroidism
  • Albright Hereditary Osteodystrophy

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Ashley Shoemaker, MD · Vanderbilt University

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-01
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02411461 on ClinicalTrials.gov